In addition to the most advanced single-use bioreactors, we also provide world-class process development and scale-up services
|
Vertical-Wheel™ Bioreactor Product Family
Our line of innovative single-use bioreactors can provide homogeneous, low-shear, and scalable mixing across a wide range of working volumes
|
Contract Research and Process Development Services
With unmatched expertise in process development for a variety of cell therapy applications, we can fulfill your research and manufacturing scale-up needs
|
Current Job Opportunities
Applications Engineer
Engineering Technician
Quality Assurance Specialist / Senior Specialist
Senior Quality Engineer (Validation Specialist)
Account Manager - Eastern North America
Engineering Technician
Quality Assurance Specialist / Senior Specialist
Senior Quality Engineer (Validation Specialist)
Account Manager - Eastern North America
Upcoming Virtual Conferences
Recent Publications, Posters, and Blogs
2021 April 7 - Cell & Gene Therapy Manufacturing & Commercialization Asia virtual presentation:
2021 January 13 - Stem Cell Research & Therapy, volume 12, article 55:
Borys et al., Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred
suspension bioreactors
2020 November 3 - RegMedNet webinar:
Scalable manufacturing of allogeneic cell therapy products using Vertical-Wheel bioreactors
2020 July 8 - Bioengineering, volume 7, issue 3:
Lembong et al., Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel
System
2020 June 13 - Journal of Visualized Experiments, issue 160:
Silva et al., Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by
Immunostaining
2020 May 7 - ISCT conference virtual presentation:
Borys et al., Overcoming bioprocess bottlenecks in the large-scale expansion of high-quality hiPSC aggregates in vertical-wheel stirred
suspension bioreactors
2020 November 3 - RegMedNet webinar:
Scalable manufacturing of allogeneic cell therapy products using Vertical-Wheel bioreactors
2020 July 8 - Bioengineering, volume 7, issue 3:
Lembong et al., Bioreactor Parameters for Microcarrier-Based Human MSC Expansion under Xeno-Free Conditions in a Vertical-Wheel
System
2020 June 13 - Journal of Visualized Experiments, issue 160:
Silva et al., Scalable Generation of Mature Cerebellar Organoids from Human Pluripotent Stem Cells and Characterization by
Immunostaining
2020 May 7 - ISCT conference virtual presentation:
2020 May 4 - Genetic Engineering and Biotechnology News article:
Roberts, Josh P., Fast Tracking Cell Therapy Manufacturing Across Borders
2020 Mar. 28 - Bioengineering publication (in press):
Lee et al., Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
2020 Jan. 22 - Phacilitate conference poster and Phacilitate:Exchange Cell and Gene Therapy blog posts:
Jung et al., Super Scalability and Robustness of Cell Therapy Manufacturing Using Vertical-Wheel Bioreactors
Blog post #2: Maximising the Yield and Quality of iPSC-Derived Therapeutic Products
Blog post #1: Innovations for Scalable Manufacturing of Allogeneic Cell Therapy Products
See more in our Resource Center
Roberts, Josh P., Fast Tracking Cell Therapy Manufacturing Across Borders
2020 Mar. 28 - Bioengineering publication (in press):
Lee et al., Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products
2020 Jan. 22 - Phacilitate conference poster and Phacilitate:Exchange Cell and Gene Therapy blog posts:
Jung et al., Super Scalability and Robustness of Cell Therapy Manufacturing Using Vertical-Wheel Bioreactors
Blog post #2: Maximising the Yield and Quality of iPSC-Derived Therapeutic Products
Blog post #1: Innovations for Scalable Manufacturing of Allogeneic Cell Therapy Products
See more in our Resource Center
Upcoming Conferences and Exhibitions
Note: participation in future conferences contingent on COVID-19 situation
Note: participation in future conferences contingent on COVID-19 situation